ClinicalTrials.gov
ClinicalTrials.gov Menu

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00084513
Recruitment Status : Completed
First Posted : June 11, 2004
Last Update Posted : February 12, 2010
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Fox Chase Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : March 2007